Here's How This Vaccine Approval From the FDA Benefits Pfizer

Here's How This Vaccine Approval From the FDA Benefits Pfizer

Source: 
Motley Fool
snippet: 
  • Pfizer's tick-borne encephalitis vaccine, Ticovac, has received approval from the FDA for administration in the U.S.
  • With a realistic market of millions of people in the U.S., the vaccine appears to be a new billion-dollar opportunity for Pfizer.
  • Aside from Ticovac, Pfizer has a number of other exciting products to drive growth.